TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03976856 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03976856 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT03128151 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01411072 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study NCT02089737 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01332526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01332526 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02809092 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT04120168 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT03760978 — Predictive Biomarker (PRD): PIM3 mRNA
Genes: PIM3
Study NCT01677611 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04092179 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04092179 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT05694819 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01643148 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01643148 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02011594 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04715633 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01824875 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03566888 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03634813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03893929 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02727140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02495103 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT02495103 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT01617733 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01023568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03453463 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04291300 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01210287 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04177238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01514266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03728127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02772679 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02772679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02772679 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03967678 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04410770 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03700892 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03700892 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04646317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02898116 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03391518 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03391518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00775385 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT00775385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00296803 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02917655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01638819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01638819 — Safety Biomarker (SAF): Interleukin 1
Study NCT01638819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01638819 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT01638819 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01638819 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT01893593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04075604 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06257004 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT04095910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02786459 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02602977 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00023244 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03087253 — Predictive Biomarker (PRD): AGPAT2 mRNA
Genes: AGPAT2
Study NCT03087253 — Predictive Biomarker (PRD): BSCL2 mRNA
Genes: BSCL2
Study NCT03087253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT03087253 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT03087253 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study NCT03087253 — Predictive Biomarker (PRD): AKT2 mRNA
Genes: AKT2
Study NCT03087253 — Predictive Biomarker (PRD): CIDEC mRNA
Genes: CIDEC; FSP27
Study NCT03087253 — Predictive Biomarker (PRD): LIPE mRNA
Genes: LIPE
Study NCT03087253 — Predictive Biomarker (PRD): PLIN1 mRNA
Genes: PLIN1; PERI; PLIN
Study NCT03087253 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study NCT03087253 — Predictive Biomarker (PRD): ZMPSTE24 mRNA
Genes: ZMPSTE24; FACE1; STE24
Study NCT03087253 — Predictive Biomarker (PRD): PSMB8 mRNA
Genes: PSMB8; LMP7; PSMB5i; RING10; Y2
Study NCT03087253 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT03087253 — Predictive Biomarker (PRD): PIK3R1 mRNA
Genes: PIK3R1; GRB1
Study NCT03087253 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT04182191 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01805271 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01805271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04411524 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00137865 — Safety Biomarker (SAF): Interleukin 12
Study NCT00611793 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00611793 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02666534 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT04539145 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03469388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02707809 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02994602 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study NCT02994602 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04655612 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00132431 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00285467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00201318 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00744458 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03461289 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT03572933 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT03798561 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01736553 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT01806727 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04154709 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02237352 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02237352 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02237352 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03046758 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03561285 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT00005406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01065597 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01065597 — Safety Biomarker (SAF): BDNF
Study NCT01271114 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02879721 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02879721 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00769210 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00570739 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00570739 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04467021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02276066 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00172354 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03675451 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04171128 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02553915 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02553915 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02553915 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04422613 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03828773 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT02012192 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02224521 — Safety Biomarker (SAF): Arachidonate 5-lipoxygenase activating protein
Genes: ALOX5AP; FLAP
Study NCT03509467 — Predictive Biomarker (PRD): MC1R mRNA
Genes: MC1R; MSHR
Study NCT01420432 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00970216 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00571272 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT01397318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03390231 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study NCT02602873 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT02261480 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03376490 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02710552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06087003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00296348 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT00673790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00560482 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT04755400 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02165228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02165228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02165228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00799799 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study NCT01256580 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03387150 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04438902 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02735317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02366598 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04122625 — Predictive Biomarker (PRD): DIABLO mRNA
Genes: DIABLO; SMAC
Study NCT04122625 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04122625 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04122625 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04122625 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT01225536 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04388657 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT04388657 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02468089 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03425994 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03425994 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03852498 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT02133521 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT02133521 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00152321 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04066179 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT04439851 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03982758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00253500 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04467541 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03654027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03654027 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03654027 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03654027 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01806974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01806974 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT01806974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04308369 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05302947 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05302947 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04617483 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03610321 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01094444 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00911664 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03591549 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03920618 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02111941 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT00492401 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT04634409 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03901521 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT05028023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04707508 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04707508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01623778 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00502710 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01408537 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00057447 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04423939 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study NCT01109706 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01109706 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT00950781 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00312780 — Predictive Biomarker (PRD): ADAM10 mRNA
Genes: ADAM10; KUZ; MADM
Study NCT00312780 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT00312780 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT01770535 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04164212 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04164212 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT02933970 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT01315236 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01759888 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT00970203 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02150837 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03311178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00891293 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00891293 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02875171 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT01614860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03488810 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00214825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00214825 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT00214825 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02728791 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00218244 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03262402 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03404934 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00001985 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT00001985 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00624832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04756180 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04756180 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02588092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT01532206 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04508556 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01672853 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study NCT02194608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01106872 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02232503 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT02352506 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT02875522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03869073 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02307526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00050713 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03070912 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03889171 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03889171 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00517686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01562015 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01777438 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03321929 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT02059993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03126253 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02035072 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT02236481 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02236481 — Safety Biomarker (SAF): Interleukin 1
Study NCT01374711 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01374711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00099528 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00679055 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT02864329 — Predictive Biomarker (PRD): PIWIL4 mRNA
Genes: PIWIL4; HIWI2; PIWI
Study NCT02927678 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04534062 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03562221 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT04120493 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01182935 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04985006 — Predictive Biomarker (PRD): PPARGC1A mRNA
Genes: PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1
Study NCT00095485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01578564 — Predictive Biomarker (PRD): TRPV6 mRNA
Genes: TRPV6; ECAC2
Study NCT05326893 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05326893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2